• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用酶联免疫吸附测定法对肝病患者血清鸟氨酸氨甲酰转移酶进行临床评估。

Clinical evaluation of serum ornithine carbamoyltransferase by enzyme-linked immunosorbent assay in patients with liver diseases.

作者信息

Watanabe Y, Mori S, Fujiyama S, Sato T, Mori M

机构信息

Third Department of Internal Medicine, Kumamoto University School of Medicine, Japan.

出版信息

Enzyme Protein. 1994;48(1):18-26. doi: 10.1159/000474965.

DOI:10.1159/000474965
PMID:7787967
Abstract

We developed a sensitive enzyme-linked immunosorbent assay (ELISA) for serum ornithine carbamoyltransferase (OCT) protein, and examined serum OCT concentrations in patients with various liver diseases. OCT concentrations were markedly elevated in cases of hepatic encephalopathy, 'acute on chronic', and those with the acute phase of acute hepatitis, moderately in chronic hepatitis, liver cirrhosis, hepatocellular carcinoma, primary biliary cirrhosis, and slightly in those with a fatty liver. High percentages (92-98%) of patients with chronic hepatitis, liver cirrhosis and hepatocellular carcinoma had higher than normal concentrations of serum OCT protein. There was a close correlation with aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activities and moderate correlations with those of mitochondrial AST, glutamate dehydrogenase and gamma-glutamyltranspeptidase. The OCT/ALT ratio was higher in patients with liver cirrhosis than in those with chronic hepatitis (p < 0.001), and was still higher in cases of hepatocellular carcinoma (p < 0.05). In 2 patients with 'acute on chronic' disease, OCT concentrations decreased similarly with or more rapidly than AST or ALT activities after admission. In 2 patients with hepatic encephalopathy, the OCT concentrations changed similarly with AST and ALT activities. This OCT ELISA system will aid in diagnosing various liver diseases and in the follow-up of the patients, and the OCT/ALT ratio may serve for a differential diagnosis of liver diseases.

摘要

我们开发了一种用于检测血清鸟氨酸氨甲酰基转移酶(OCT)蛋白的灵敏酶联免疫吸附测定法(ELISA),并检测了各种肝病患者的血清OCT浓度。在肝性脑病、“慢性肝急性发作”以及急性肝炎急性期患者中,OCT浓度显著升高;在慢性肝炎、肝硬化、肝细胞癌、原发性胆汁性肝硬化患者中,OCT浓度中度升高;在脂肪肝患者中,OCT浓度轻度升高。慢性肝炎、肝硬化和肝细胞癌患者中,血清OCT蛋白浓度高于正常水平的比例较高(92 - 98%)。血清OCT浓度与天冬氨酸氨基转移酶(AST)和丙氨酸氨基转移酶(ALT)活性密切相关,与线粒体AST、谷氨酸脱氢酶和γ-谷氨酰转肽酶活性中度相关。肝硬化患者的OCT/ALT比值高于慢性肝炎患者(p < 0.001),肝细胞癌患者的该比值更高(p < 0.05)。在2例“慢性肝急性发作”患者中,入院后OCT浓度下降情况与AST或ALT活性相似或更快。在2例肝性脑病患者中,OCT浓度变化与AST和ALT活性相似。这种OCT ELISA系统将有助于各种肝病的诊断和患者的随访,OCT/ALT比值可能有助于肝病的鉴别诊断。

相似文献

1
Clinical evaluation of serum ornithine carbamoyltransferase by enzyme-linked immunosorbent assay in patients with liver diseases.采用酶联免疫吸附测定法对肝病患者血清鸟氨酸氨甲酰转移酶进行临床评估。
Enzyme Protein. 1994;48(1):18-26. doi: 10.1159/000474965.
2
Involvement of Ornithine Carbamoyltransferase in the Progression of Chronic Hepatitis C and Liver Cirrhosis.精氨酸氨甲酰转移酶在慢性丙型肝炎及肝硬化进展中的作用。
Int J Med Sci. 2017 Jun 14;14(7):629-638. doi: 10.7150/ijms.17641. eCollection 2017.
3
Investigation of ornithine carbamoyltransferase as a biomarker of liver cirrhosis.鸟氨酸氨基甲酰转移酶作为肝硬化生物标志物的研究。
Intern Med. 2014;53(12):1249-57. doi: 10.2169/internalmedicine.53.1944. Epub 2014 Jun 15.
4
Ratio of serum ornithine carbamoyltransferase to alanine aminotransferase as a potent indicator for hepatocellular carcinoma.血清鸟氨酸氨基甲酰转移酶与丙氨酸氨基转移酶的比值作为肝细胞癌的有效指标。
Clin Biochem. 2007 Sep;40(13-14):1077-80. doi: 10.1016/j.clinbiochem.2007.05.001. Epub 2007 May 24.
5
Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma.回顾性评估血清标志物APRI和AST/ALT在慢性乙型和丙型肝炎合并肝细胞癌患者中评估肝纤维化和肝硬化的价值。
Intern Med. 2008;47(7):569-75. doi: 10.2169/internalmedicine.47.0595. Epub 2008 Apr 1.
6
A sensitive enzyme-linked immunosorbent assay of serum ornithine carbamoyltransferase.血清鸟氨酸氨基甲酰转移酶的灵敏酶联免疫吸附测定法。
Enzyme Protein. 1994;48(1):10-7. doi: 10.1159/000474964.
7
The mechanism of the release of hepatic enzymes in various liver diseases. 1. Alterations in cytoplasmic and mitochondrial enzyme activities in serum.
Acta Med Okayama. 1979 Aug;33(4):287-304.
8
Superiority of serum type-I arginase and ornithine carbamyltransferase in the detection of toxicant-induced acute hepatic injury in rats.血清I型精氨酸酶和鸟氨酸氨基甲酰转移酶在检测大鼠毒物诱导的急性肝损伤中的优越性。
Clin Chim Acta. 2008 May;391(1-2):31-5. doi: 10.1016/j.cca.2008.01.023. Epub 2008 Jan 31.
9
Clinical evaluation of serum guanase activity in liver diseases.肝脏疾病中血清鸟嘌呤酶活性的临床评估
Clin Biochem. 1984 Oct;17(5):327-30. doi: 10.1016/s0009-9120(84)90661-1.
10
Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis.慢性肝炎中血清天冬氨酸与丙氨酸转氨酶的比值。与肝硬化的关系。
Gastroenterology. 1988 Sep;95(3):734-9. doi: 10.1016/s0016-5085(88)80022-2.

引用本文的文献

1
Involvement of Ornithine Carbamoyltransferase in the Progression of Chronic Hepatitis C and Liver Cirrhosis.精氨酸氨甲酰转移酶在慢性丙型肝炎及肝硬化进展中的作用。
Int J Med Sci. 2017 Jun 14;14(7):629-638. doi: 10.7150/ijms.17641. eCollection 2017.